Related Experiment Video
Updated: Jul 6, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Two of four alternatively spliced isoforms of RUNX2 control osteocalcin gene expression in human osteoblast cells
Naoyuki Makita1, Mitsuhiro Suzuki, Shiori Asami
1Research Institute for Biological Sciences, Tokyo University of Science, Chiba, Japan.
Abstract:
Runx2 is a Runt domain transcription factor that transcriptionally regulates osteoblast differentiation and bone formation. In this study, we show that human chondro- and osteosarcoma cell lines, human mesenchymal stem cells (hMSC) and a human primary chondrocytes (HC), osteoblst cells (HOb) express an intact isoform (RUNX2wt) and 3 alternatively spliced isoforms (RUNX2Delta5, Delta7, and Delta5Delta7) that are generated by skipping exon 5 and/or exon 7. Two of the truncated forms of RUNX2 (RUNX2Delta5 and RUNX2Delta5Delta7) did not localize in the nucleus and had lost their DNA binding activity. In cotransfection experiments with an osteocalcin (OC) promoter construct, we confirmed that only RUNX2wt and RUNX2Delta7 could upregulate the OC promoter activity in the osteosarcoma cell line. In addition, the coactivator CBP/p300 enhanced the transcriptional activity of the OC promoter when coexpressed with RUNX2wt or RUNX2Delta7, but not when coexpressed with RUNX2Delta5 or RUNX2Delta5Delta7. In contrast, the corepressor HDAC3 only repressed the activation from the OC promoter when coexpressed with RUNX2wt. These results support the hypothesis that RUNX2 both up- and downregulates its target gene promoters, as exemplified by the OC gene, using various isoforms and context-dependent formation of transcriptional complexes.
Insights
Runx2 (Runt-related transcription factor 2) isoforms regulate bone formation. Specific isoforms like RUNX2wt and RUNX2Delta7 activate osteocalcin gene expression, while others are inactive.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Runx2 is a key transcription factor regulating osteoblast differentiation and bone formation.
- Alternative splicing of Runx2 generates multiple isoforms with potentially distinct functions.
Purpose of the Study:
- To investigate the expression and function of different Runx2 isoforms in bone-related cells.
- To determine how these isoforms affect the transcriptional regulation of the osteocalcin gene.
Main Methods:
- Analysis of Runx2 isoform expression in human cell lines (chondrosarcoma, osteosarcoma, hMSC, HOb).
- Assessment of DNA binding activity and nuclear localization of Runx2 isoforms.
- Cotransfection assays using an osteocalcin promoter construct with various Runx2 isoforms, coactivators (CBP/p300), and corepressors (HDAC3).
Main Results:
- Human bone-related cells express intact RUNX2wt and three alternatively spliced isoforms (RUNX2Delta5, RUNX2Delta7, RUNX2Delta5Delta7).
- RUNX2Delta5 and RUNX2Delta5Delta7 isoforms lack nuclear localization and DNA binding activity.
- Only RUNX2wt and RUNX2Delta7 could upregulate osteocalcin promoter activity, with differential modulation by coactivators and corepressors.
Conclusions:
- Runx2 isoforms exhibit distinct functional properties, impacting their role in transcriptional regulation.
- The activity of Runx2 isoforms is context-dependent, influenced by cofactors and cellular environment.
- Runx2 plays a dual role in regulating target gene promoters, involving both activation and repression through different isoforms.
More Related Videos
Related Concept Videos
RNA Splicing
Master Transcription Regulators
Osteoclasts in Bone Remodeling
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
General Transcription Factors

